Abatacept dose-finding phase II triaL for immune checkpoint inhibitors myocarditis (ACHLYS) trial design

Authors

Yves Allenbach (ORCID: https://orcid.org/0000-0002-3185-7993)
Noël Zahr (ORCID: https://orcid.org/0000-0002-7858-2325)
Lisa Belin (ORCID: https://orcid.org/0000-0002-7628-6629)
Stéphane Éderhy (ORCID: https://orcid.org/0000-0002-0792-2521)
Florence Tubach (ORCID: https://orcid.org/0000-0002-7802-944X)
Adrien Procureur (ORCID: https://orcid.org/0000-0003-3486-5208)
Marie Bretagne (ORCID: https://orcid.org/0000-0001-8170-9991)
Joe‐Elie Salem (ORCID: https://orcid.org/0000-0002-0331-3307)
Michelle Rosenzwjag

Institutions

Inserm (FR)
Sorbonne Université (FR)
Assistance Publique – Hôpitaux de Paris (FR)
Hôpital Saint-Antoine (FR)
Pitié-Salpêtrière Hospital (FR)
Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR)

Publication Details

Journal: Archives of cardiovascular diseases
Published: 2024-12-20
DOI: https://doi.org/10.1016/j.acvd.2024.12.005
Citations: 21
Primary Topic: Cancer Immunotherapy and Biomarkers
Type: article
Field-Weighted Citation Impact: 5.93

Funders

Fédération Française de Cardiologie

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Abatacept dose-finding phase II triaL for immune checkpoint inhibitors myocarditis (ACHLYS) trial design

Yves Allenbach, Noël Zahr, Lisa Belin, Stéphane Éderhy et al.

Dec 20, 2024

21 citations

Archives of cardiovascular diseases

Cancer Immunotherapy and Biomarkers

5.93

article

Abatacept dose-finding phase II triaL for immune checkpoint inhibitors myocarditis (ACHLYS) trial design

Yves Allenbach, Noël Zahr, Lisa Belin, Stéphane Éderhy, Florence Tubach, Adrien Procureur, Marie Bretagne, Joe‐Elie Salem, Michelle Rosenzwjag

December 20, 2024article en

21 citations

Abstract

No abstract available for this paper.

Archives of cardiovascular diseasesVol. 118(2)

Inserm (FR), Sorbonne Université (FR), Assistance Publique – Hôpitaux de Paris (FR), Hôpital Saint-Antoine (FR), Pitié-Salpêtrière Hospital (FR), Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR)

Fédération Française de Cardiologie

Good health and well-being

Openalex Percentile: Top 3%

Cancer Immunotherapy and Biomarkers

5.93

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.